Showing results (211-220 of 222) with videos related to
Sort By:
Pageof 23
Marine Pollution Bulletin|April 12, 2021
Synthesis and evaluation of coastal and marine biodiversity spatial information in the United Arab Emirates for ecosystem-based managementD Mateos-Molina, E Ben Lamine, M Antonopoulou, et al.Gastroenterology|April 30, 2022
β-Catenin Sustains and Is Required for YES-associated Protein Oncogenic Activity in CholangiocarcinomaYi Zhang, Hongwei Xu, Guofei Cui, et al.Cell Reports|July 7, 2021
Compensatory hepatic adaptation accompanies permanent absence of intrahepatic biliary network due to YAP1 loss in liver progenitorsLaura M Molina, Junjie Zhu, Qin Li, et al.Molecular and Cellular Biology|May 30, 2019
Impaired Ribosomal Biogenesis by Noncanonical Degradation of β-Catenin during HyperammonemiaGangarao Davuluri, Michela Giusto, Rajeev Chandel, et al.Cancer Discovery|June 13, 2019
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular CarcinomaMarina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, et al.Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.Nature|January 31, 2024
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liverWeiguo Fan, Kolade Adebowale, Lóránd Váncza, et al.Research Square|December 23, 2024
Precision targeting of β-catenin induces tumor reprogramming and immunity in hepatocellular cancersBrandon M Lehrich, Evan R Delgado, Tyler M Yasaka, et al.Cancer Research|September 5, 2019
Recent Developments and Therapeutic Strategies against Hepatocellular CarcinomaMark Yarchoan, Parul Agarwal, Augusto Villanueva, et al.Cell|December 23, 2025
Hepatic adaptation to chronic metabolic stress primes tumorigenesisConstantine N Tzouanas, Jessica E S Shay, Marc S Sherman, et al.Pageof 23